Name Funds
holding
Growth Growth % Return since
30 Sep ‘13
101
155 +19 +14% 90.6%
102
131 +16 +14% 228%
103
115 +14 +14% 106%
LGND icon
104
Ligand Pharmaceuticals
LGND
$4.02B
132 +16 +14% 656%
105
75 +9 +14% 376%
106
177 +21 +13% 17.6%
107
358 +42 +13% 64.8%
108
87 +10 +13% 355%
109
201 +23 +13% 31.8%
110
246 +28 +13% 17.9%
CALX icon
111
Calix
CALX
$3.48B
124 +14 +13% 313%
112
36 +4 +13% 99.9%
113
18 +2 +13% 1,258%
114
9 +1 +13%
115
192 +21 +12% 243%
116
111 +12 +12% 11.6%
117
37 +4 +12% 79.5%
118
139 +15 +12% 197%
119
131 +14 +12% 111%
120
103 +11 +12% 324%
121
103 +11 +12% 36.7%
122
104 +11 +12% 225%
123
57 +6 +12% 1.42%
124
38 +4 +12% 673%
125
200 +21 +12% 26.3%